Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma

被引：60

作者：

Hedstrom, Gustaf ^{[1
]}

Berglund, Mattias

Molin, Daniel

Fischer, Marie

Nilsson, Gunnar

Thunberg, Ulf

Book, Majlis

Sundstrom, Christer

Rosenquist, Richard

Roos, Goran

Erlanson, Martin

Amini, Rose-Marie

Enblad, Gunilla

机构：

[1] Uppsala Univ, Rudbeck Lab, Dept Oncol, S-75145 Uppsala, Sweden

[2] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, S-75145 Uppsala, Sweden

[3] Karolinska Inst, Dept Med, Stockholm, Sweden

[4] Univ Uppsala, Dept Genet & Pathol, S-75105 Uppsala, Sweden

[5] Uppsala Univ, Dept Biosci, Uppsala, Sweden

[6] Umea Univ, Dept Radiat Sci Oncol, Umea, Sweden

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2007年 / 138卷 / 01期

关键词：

mast cells; non-Hodgkin lymphoma; prognostic factors;

D O I：

10.1111/j.1365-2141.2007.06612.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Previous studies indicate that the inflammatory response in diffuse large B-cell lymphomas (DLBCL) is important for the clinical outcome. Mast cells are key regulators in this response; we investigated whether the number of tryptase-positive mast cells is correlated with clinical outcome. Patients with many mast cells had a significantly better event-free survival (EFS) compared to those with few mast cells (P < 0.03 in both germinal centre (GC) and non-GC DLBCL. This supports the idea that the infiltration of mast cells is a reflection of the host inflammatory response and is related to a favourable outcome.

引用

页码：68 / 71

页数：4

共 50 条

[41] Diffuse large B-cell lymphoma
Alcantara, Marion
Huynh, Tony
HEMATOLOGIE, 2016, 22 (02): : 159 - 166
[42] OSTEOPONTIN AS PRONOSTIC FACTOR OF DIFFUSE LARGE B-CELL LYMPHOMA
Barranco Lampon, G. I.
Ruiz Garcia, E. B.
Fernandez Figueroa, E. A.
Rivas Vera, M. S.
Lome Maldonado, C.
Quezada Lopez, R.
Cortes, E.
Aguilar Ponce, J. L.
HAEMATOLOGICA, 2017, 102 : 698 - 699
[43] Prognostic markers and angiogenesis in diffuse large B-cell lymphoma and follicular lymphoma
Mezei, T.
Gurzu, S.
Raica, M.
Cimpean, A.
Szentirmay, J.
Jung, J.
VIRCHOWS ARCHIV, 2009, 455 : 17 - 18
[44] Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-cell Lymphoma
Alonso-Alvarez, Sara
Alcoceba, Miguel
Garcia-Alvarez, Maria
Blanco, Oscar
Rodriguez, Marta
Baile, Monica
Carlos Caballero, Juan
Davila, Julio
Belen Vidriales, Maria
Esteban, Carmen
Arias, Piedad
Diaz, Luis G.
Tamayo, Pilar
Dolores Caballero, Maria
Gutierrez, Norma C.
Gonzalez, Marcos
Martin, Alejandro
CANCERS, 2020, 12 (02)
[45] Constitutively activation of STAT3 is a prognostic factor in activated B-cell subtype of diffuse large B-cell lymphoma
Huang, Xin
Cao, Wenfeng
Igbal, Javeed
Meng, Bin
Ding, B. Belinda
Bi, Chengfeng
Jiang, Chunsun
Ye, B. Hilda
Chan, Wing C.
Fu, Kai
CANCER RESEARCH, 2012, 72
[46] Serum B-cell activating factor (BAFF) in diffuse large B-cell lymphoma: Its prognostic significance in the rituximab era
Kim, Seok Jin
Sung, Hwa Jung
Choi, Chul Won
Kim, In Sun
Kim, Byung Soo
Yoon, Soo-Young
Won, Jong-Ho
Kim, Jun Suk
BLOOD, 2007, 110 (11) : 470A - 471A
[47] Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy
Jamil, Muhammad O.
Mehta, Amitkumar
EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (05) : 471 - 477
[48] A prognostic immune risk score for diffuse large B-cell lymphoma
Ma, Shu-Yun
Tian, Xiao-Peng
Cai, Jun
Su, Ning
Fang, Yu
Zhang, Yu-Chen
Wang, Jin-Ni
Peter Gale, Robert
Cai, Qing-Qing
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (01) : 111 - 119
[49] Identification of prognostic factors in patients with diffuse large B-cell lymphoma
Peng, Fang
Guo, Liang
Yao, Wei-Kai
Zheng, Yan
Liu, Ye
Duan, Xiu-Mei
Wang, Yin-Ping
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2017, 60 (01) : 87 - 91
[50] Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma
Han, Xiao
Ruan, Jing
Zhang, Wei
Zhou, Daobin
Xu, Dongsheng
Pei, Qiang
Ouyang, Mingqi
Zuo, Mengxuan
ONCOTARGET, 2017, 8 (29) : 47790 - 47800

← 1 2 3 4 5 →